Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. [electronic resource]
Producer: 20100114Description: 9-17 p. digitalISSN:- 1533-4406
- Administration, Intranasal
- Anti-Infective Agents -- adverse effects
- Carrier State -- drug therapy
- Cause of Death
- Chlorhexidine -- adverse effects
- Cross Infection -- prevention & control
- Double-Blind Method
- Female
- Hospital Mortality
- Humans
- Kaplan-Meier Estimate
- Length of Stay
- Logistic Models
- Male
- Middle Aged
- Mupirocin -- adverse effects
- Nasal Cavity -- microbiology
- Ointments
- Polymerase Chain Reaction
- Skin -- microbiology
- Soaps -- therapeutic use
- Staphylococcal Infections -- prevention & control
- Staphylococcus aureus -- genetics
- Surgical Wound Infection -- prevention & control
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.